Literature DB >> 813917

Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery.

S Franks, H S Jacobs, J D Nabarro.   

Abstract

Basal serum prolactin and growth hormone (GH) concentrations were measured by radioimmunoassay in forty patients with acromegaly. GH concentrations were elevated in all patients studied before treatment and prolactin levels were raised in seven of twenty-six patients. Of the thirty-two patients reviewed after treatment (which in most cases was transsphenoidal hypophysectomy) twenty-five had GH concentrations below 5 ng/ml and twenty-nine had normal prolactin levels. In eighteen patients hormone measurements were made both before and after hypophysectomy: though GH levels fell in all but one, prolactin fell in only six patients. They were not significantly changed in eleven patients. There was no correlation of GH and prolactin either before or after surgery. Seven patients had greatly elevated prolactin levels and in four of these there was evidence of upward extension of a pituitary tumour on air encephalogram (AEG). Only one patient with a normal prolactin level had an abnormal AEG. Two patients with elevated prolactin concentrations and normal AEGs had a parallel fall of prolactin and GH in response to surgery. Four of the five hyperprolactinaemic men complained of loss of libido: in three gonadotrophin concentrations before and after treatment were normal. We conclude that there is no overall correlation of GH and prolactin levels in patients with acromegaly. Seven of twenty-six untreated patients (27%) had hyperprolactinaemia. We suggest that in these patients a raised prolactin level may be due either to interference with the normal inhibitory control mechanism of prolactin by suprasellar extension or, more rarely, to secretion of both GH and prolactin by the tumour itself. A high prolactin concentration may be the cause of the impotence of which some patients with acromegaly complain.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 813917

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

1.  Management of acromegaly.

Authors:  J D Nabarro
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1976

Review 2.  Management of endocrine disorders in pregnancy. Part II. Pituitary, ovarian and adrenal disease.

Authors:  Z M van der Spuy; H S Jacobs
Journal:  Postgrad Med J       Date:  1984-05       Impact factor: 2.401

Review 3.  Sexual behavior of the male schizophrenic: the impact of illness and medications.

Authors:  J N Nestoros; H E Lehmann; T A Ban
Journal:  Arch Sex Behav       Date:  1981-10

4.  Peripartum cardiomyopathy in a patient with hyperprolactinaemia.

Authors:  G S Matharu; M H Oelbaum
Journal:  Postgrad Med J       Date:  1984-01       Impact factor: 2.401

5.  Cardiomegaly and heart failure in a patient with prolactin-secreting pituitary tumour.

Authors:  G Curtarelli; C Ferrari
Journal:  Thorax       Date:  1979-06       Impact factor: 9.139

6.  Role of cell and explant culture in the diagnosis and characterization of human pituitary tumours.

Authors:  E F Adams; K Mashiter
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

7.  Pituitary adenomas in acromegaly: Comparison of different adenoma types with clinical data.

Authors:  D Voit; W Saeger; D K Lüdecke
Journal:  Endocr Pathol       Date:  1999-06       Impact factor: 3.943

8.  Amenorrhea-galactorrhea associated with Cushing's disease due to pituitary tumor.

Authors:  S Rodriguez; M Alger; G Forsbach; S N Contreras; E S Canales; A Zarate
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

Review 9.  Cerebrospinal fluid rhinorrhoea in pituitary tumours.

Authors:  I E Cole; M Keene
Journal:  J R Soc Med       Date:  1980-04       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.